|100.47||+1.80 / +1.82%|
Data as of 4:00pm ET
|100.47||0.00 / 0.00%|
The 13 analysts offering 12-month price forecasts for Cubist Pharmaceuticals Inc have a median target of 102.00, with a high estimate of 102.00 and a low estimate of 77.00. The median estimate represents a +1.52% increase from the last price of 100.47.
The current consensus among 17 polled investment analysts is to Hold stock in Cubist Pharmaceuticals Inc. This rating has held steady since December, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.